People · Operator
Named in public records as an officer, director or promoter · active 2014–2024 · Other, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Silk, Inc. | — | Other | Series B | $48.5M | $497.8M | 2014 |
| Immunis, Inc. | — | Biotechnology | Series B | $20.4M | $147.9M | 2024 |
| Sitrion Holdings, Inc. | — | Other Technology | Pre-Seed | $500K | $21.2M | 2014 |
Daniel Kraft at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Kraft on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| RICHARD LEVANDOV | 1 | 20 |
| Jeffrey Vinik | 1 | 4 |
| Hans Keirstead | 1 | 3 |
| Bradley Feld | 1 | 3 |
| Takahide Koda | 1 | 3 |
| Brendan O'Leary | 1 | 3 |
| Roy Disney | 1 | 2 |
| Gregory Altman | 1 | 2 |
| Lisa Reeves | 1 | 2 |
| Rebecca Lacouture | 1 | 2 |
| Robert Pangia | 1 | 2 |
| Craig Lamborn | 1 | 1 |
| Bill Forquer | 1 | 1 |
| Gabriel Nistor | 1 | 1 |
| Sheri Disney | 1 | 1 |
| Scott Packard | 1 | 1 |
| Rebecca Horan | 1 | 1 |
| J.B. Holston, III | 1 | 1 |
| Greg Reinacker | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.